![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Applications:
Sustained Release (Insoluble & High Permeability)
Ingredient(s): Ammonio Methacrylate Copolymer
Dosage Form: Tablet, Transdermal Patch
Category: Controlled & Modified Release
Technical Specifications: Not Available
Applications:
Sustained release (Insoluble & Low Permeability)
Ingredient(s): Ammonio Methacrylate Copolymer Type B
Dosage Form: Tablet, Transdermal Patch
Category: Controlled & Modified Release
Technical Specifications: Not Available
Applications:
Sustained Release (Insoluble & High Permeability)
Ingredient(s): Ammonio Methacrylate Copolymer Type B
Dosage Form: Tablet, Transdermal Patch
Category: Controlled & Modified Release
Technical Specifications: Not Available
Applications:
Sustained Release (Insoluble & High Permeability)
Ingredient(s): Ammonio Methacrylate Copolymer Type B
Dosage Form: Tablet, Transdermal Patch
Category: Controlled & Modified Release
Technical Specifications: Not Available